Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL

被引:29
作者
Habu, Y
Miyano-Kurosaki, N
Kitano, M
Endo, Y
Yukita, M
Ohira, S
Takaku, H [1 ]
Nashimoto, M
Takaku, H [1 ]
机构
[1] Chiba Inst Technol, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Chiba 2750016, Japan
[2] Chiba Inst Technol, High Technol Res Ctr, Chiba 2750016, Japan
[3] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata 9568603, Japan
关键词
D O I
10.1093/nar/gki164
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tRNA 3'-processing endoribonuclease (tRNase Z or 3' tRNase; EC 3.1.26.11) is an essential enzyme that removes the 3' trailer from pre-tRNA. The long form (tRNase ZL) can cleave a target RNA in vitro at the site directed by an appropriate small-guide RNA (sgRNA). Here, we investigated whether this sgRNA/tRNase ZL strategy could be applied to gene therapy for AIDS. We tested the ability of four sgRNA-expression plasmids to inhibit HIV-1 gene expression in COS cells, using a transient-expression assay. The three sgRNAs guide inhibition of HIV-1 gene expression in cultured COS cells. Analysis of the HIV-1 mRNA levels suggested that sgRNA directed the tRNase ZL to mediate the degradation of target RNA. The observation that sgRNA was localized primarily in nuclei suggests that tRNase ZL cleaves the HIV-1 mRNA when complexed with sgRNA in this location. We also examined the ability of two retroviral vectors expressing sgRNA to suppress HIV-1 expression in HIV-1-infected Jurkat T cells. sgRNA-SL4 suppressed HIV-1 expression almost completely in infected cells for up to 18 days. These results suggest that the sgRNA/tRNase ZL approach is effective in downregulating HIV-1 gene expression.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 45 条
[1]   High-efficiency gene transfer into CD34(+) cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G [J].
Akkina, RK ;
Walton, RM ;
Chen, ML ;
Li, QX ;
Planelles, V ;
Chen, ISY .
JOURNAL OF VIROLOGY, 1996, 70 (04) :2581-2585
[2]   Effective inhibition of HIV-1 replication in cultured cells by external guide sequences and ribonuclease P [J].
Barnor, JS ;
Endo, Y ;
Habu, Y ;
Miyano-Kurosaki, N ;
Kitano, M ;
Yamamoto, H ;
Takaku, H .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (19) :4941-4944
[3]   Gene therapy for infectious diseases [J].
Bunnell, BA ;
Morgan, RA .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) :42-+
[4]   VESICULAR STOMATITIS-VIRUS G GLYCOPROTEIN PSEUDOTYPED RETROVIRAL VECTORS - CONCENTRATION TO VERY HIGH-TITER AND EFFICIENT GENE-TRANSFER INTO MAMMALIAN AND NONMAMMALIAN CELLS [J].
BURNS, JC ;
FRIEDMANN, T ;
DRIEVER, W ;
BURRASCANO, M ;
YEE, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :8033-8037
[5]   RNA structure and packaging signals in the 5′ leader region of the human immunodeficiency virus type 1 genome [J].
Clever, JL ;
Miranda, D ;
Parslow, TG .
JOURNAL OF VIROLOGY, 2002, 76 (23) :12381-12387
[6]   FACS-optimized mutants of the green fluorescent protein (GFP) [J].
Cormack, BP ;
Valdivia, RH ;
Falkow, S .
GENE, 1996, 173 (01) :33-38
[7]  
Dornburg R, 2000, GENE THERAPY, P519
[8]   ARTIFICIAL REGULATION OF GENE-EXPRESSION IN ESCHERICHIA-COLI BY RNASE-P [J].
GUERRIERTAKADA, C ;
LI, Y ;
ALTMAN, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11115-11119
[9]  
Habu Yuichiro, 2002, Antivir Chem Chemother, V13, P273
[10]   Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis [J].
Hnatyszyn, HJ ;
Spruill, G ;
Young, AK ;
Seivright, R ;
Kraus, G .
GENE THERAPY, 2001, 8 (24) :1863-1871